Phytochemicals: Cancer chemoprevention and suppression of tumor onset and metastasis

Cancer and Metastasis Reviews

Volumn 29, Issue 3, 2010, Pages 483-502

  Shu, Limin ^a   Cheung, Ka Lung ^a   Khor, Tin Oo ^a   Chen, Chi ^b   Kong, Ah Ng ^a  

^a RUTGERS UNIVERSITY   (United States)

^b NONE

Author keywords

Cancer chemoprevention; Herbs; Metastasis; Molecular targets; Phytochemicals

Indexed keywords

(6) GINGEROL; ALKALOID; ARTESUNATE; BETA CAROTENE; CAFFEINE; CAROTENOID; COLECALCIFEROL; CURCUMIN; EMODIN; EPIGALLOCATECHIN GALLATE; GENISTEIN; GINSENOSIDE; HONOKIOL; ISOFLAVONE; LICOCHALCONE A; LYCOPENE; MATRINE; PLANT MEDICINAL PRODUCT; PLUMBAGIN; POLYPHENOL; QUERCETIN; RESVERATROL; RHEIN; SELENIUM; SOLAMARGINE; SULFORAPHANE; TANSHINONE; THYMOQUINONE; UNINDEXED DRUG; WOGONIN;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BLADDER TUMOR; CANCER CELL; CANCER INCIDENCE; CANCER INHIBITION; CANCER INVASION; CANCER PREVENTION; CARCINOGENESIS; CATHARANTHUS; CATHARANTHUS ROSEUS; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CURCUMA LONGA; EPITHELIAL MESENCHYMAL TRANSITION; HEPATOMA CELL; HUMAN; LUNG METASTASIS; MELANOMA CELL; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TAXUS BREVIFOLIA; TEA; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; PHYTOTHERAPY; SIGNAL TRANSDUCTION;

EID: 77957587417     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-010-9239-y     Document Type: Review

References (273)

1. JA Boyd JC Barrett 1990 Genetic and cellular basis of multistep carcinogenesis Pharmacology & Therapeutics 46 3 469 486 1:STN:280: DyaK3c3mtVSisg%3D%3D
2. P Armitage 1985 Multistage models of carcinogenesis Environmental Health Perspectives 63 195 201 1:CAS:528:DyaL28XmtlClsg%3D%3D 3908088
3. C Fimognari M Lenzi P Hrelia 2008 Chemoprevention of cancer by isothiocyanates and anthocyanins: mechanisms of action and structure-activity relationship Current Medicinal Chemistry 15 5 440 447 1:CAS:528: DC%2BD1cXnsVyisLs%3D 18288999
4. L Ottini, et al. 2006 Patterns of genomic instability in gastric cancer: clinical implications and perspectives Annals of Oncology 17 Suppl 7 vii97 vii102 16760303
5. GJ Kelloff, et al. 1999 Progress in cancer chemoprevention Annals of the New York Academy of Sciences 889 1 13 1:CAS:528:DC%2BD3cXnt1SnsA%3D%3D 10668477
6. MB Sporn, et al. 1976 Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids) Federation Proceedings 35 6 1332 1338 1:CAS:528:DyaE28XktFems7k%3D 770206
7. LW Wattenberg 1966 Chemoprophylaxis of carcinogenesis: a review Cancer Research 26 7 1520 1526 1:CAS:528:DyaF28XksVWlsLk%3D 5330111
8. AS Tsao ES Kim WK Hong 2004 Chemoprevention of cancer CA: A Cancer Journal for Clinicians 54 3 150 180
9. P Greenwald 2002 Cancer chemoprevention BMJ 324 7339 714 718 1:CAS:528:DC%2BD38XjtlyrsLw%3D 11909790
10. Johnson, S. M., Wang, X., & Mark Evers, B. (2009). Triptolide inhibits proliferation and migration of colon cancer cells by inhibition of cell cycle regulators and cytokine receptors. Journal of Surgical Research. doi: 10.1016/j.jss.2009.07.002.
11. HE Ganther 1999 Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase Carcinogenesis 20 9 1657 1666 1:CAS:528:DyaK1MXlvFWqsL8%3D 10469608
12. KL Cheung, et al. 2010 Differential in vivo mechanism of chemoprevention of tumor formation in azoxymethane/dextran sodium sulfate mice by PEITC and DBM Carcinogenesis 31 5 880 885 1:CAS:528:DC%2BC3cXlvVWjsbk%3D 19959557
13. FH Sarkar Y Li 2002 Mechanisms of cancer chemoprevention by soy isoflavone genistein Cancer and Metastasis Reviews 21 3-4 265 280 1:CAS:528:DC%2BD38XptFejs78%3D 12549765
14. YW Chin, et al. 2006 Drug discovery from natural sources The AAPS Journal 8 2 E239 E253 1:CAS:528:DC%2BD28Xks1KltL0%3D 16796374
15. J Jiang C Hu 2009 Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa Molecules 14 5 1852 1859 1:CAS:528:DC%2BD1MXmvVCmtbw%3D 19471205
16. NB Kumar K Allen H Bell 2005 Perioperative herbal supplement use in cancer patients: potential implications and recommendations for presurgical screening Cancer Control 12 3 149 157 16062162
17. SS Shord K Shah A Lukose 2009 Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals Integrative Cancer Therapies 8 3 208 227 1:CAS:528:DC%2BD1MXhtlagu73I 19815591
18. E Ho JD Clarke RH Dashwood 2009 Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention The Journal of Nutrition 139 12 2393 2396 1:CAS:528:DC%2BC3cXhsFeisLk%3D 19812222
19. AM Bode Z Dong 2004 Targeting signal transduction pathways by chemopreventive agents Mutation Research 555 1-2 33 51 1:CAS:528: DC%2BD2cXot12hu7s%3D 15476850 (Pubitemid 39345396)
20. DJ Newman GM Cragg KM Snader 2000 The influence of natural products upon drug discovery Natural Product Reports 17 3 215 234 1:CAS:528: DC%2BD3cXjt1GrsbY%3D 10888010
21. R van Der Heijden, et al. 2004 The Catharanthus alkaloids: pharmacognosy and biotechnology Current Medicinal Chemistry 11 5 607 628
22. NH Oberlies DJ Kroll 2004 Camptothecin and taxol: historic achievements in natural products research Journal of Natural Products 67 2 129 135 1:CAS:528:DC%2BD2cXkt1Cmtw%3D%3D 14987046
23. ME Wall MC Wani 1996 Camptothecin and taxol: from discovery to clinic Journal of Ethnopharmacology 51 1-3 239 253 1:CAS:528:DyaK28XisFyjs78%3D 9213622 discussion 253-4
24. BB Aggarwal A Kumar AC Bharti 2003 Anticancer potential of curcumin: preclinical and clinical studies Anticancer Research 23 1A 363 398 1:CAS:528:DC%2BD3sXislaqtLo%3D 12680238
25. G Bar-Sela R Epelbaum M Schaffer 2010 Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications Current Medicinal Chemistry 17 3 190 197 1:CAS:528:DC%2BC3cXhsVSls7k%3D 20214562
26. S Swami, et al. 2009 Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients International Journal of Cancer 124 9 2050 2059 1:CAS:528:DC%2BD1MXktVWntbY%3D
27. H Itokawa, et al. 2008 Plant-derived natural product research aimed at new drug discovery Journal of Natural Medicines 62 3 263 280 1:CAS:528:DC%2BD1cXos1altrs%3D 18425692
28. Y Lu CS Li Q Dong 2008 Chinese herb related molecules of cancer-cell-apoptosis: a minireview of progress between Kanglaite injection and related genes Journal of Experimental & Clinical Cancer Research 27 31
29. MJ Balunas AD Kinghorn 2005 Drug discovery from medicinal plants Life Sciences 78 5 431 441 1:CAS:528:DC%2BD2MXht1ejsrbP 16198377
30. IT Johnson 2007 Phytochemicals and cancer The Proceedings of the Nutrition Society 66 2 207 215 1:CAS:528:DC%2BD2sXns1alsbo%3D 17466103
31. TH Rushmore CB Pickett 1993 Glutathione S-transferases, structure, regulation, and therapeutic implications The Journal of Biological Chemistry 268 16 11475 11478 1:CAS:528:DyaK3sXksVersb8%3D 8505281
32. W Miao, et al. 2005 Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: direct cross-talk between phase I and II drug-metabolizing enzymes The Journal of Biological Chemistry 280 21 20340 20348 1:CAS:528:DC%2BD2MXktlCmurg%3D 15790560
33. M McMahon, et al. 2001 The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes Cancer Research 61 8 3299 3307 1:CAS:528:DC%2BD3MXjtFSjtb4%3D 11309284
34. K Chan XD Han YW Kan 2001 An important function of Nrf2 in combating oxidative stress:detoxification of acetaminophen Proceedings of the National Academy of Sciences of the United States of America 98 8 4611 4616 1:CAS:528:DC%2BD3MXjtVagurg%3D 11287661
35. TH Rushmore MR Morton CB Pickett 1991 The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity The Journal of Biological Chemistry 266 18 11632 11639 1:CAS:528:DyaK3MXltVOmsLY%3D 1646813
36. W Li, et al. 2008 Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis Biochemical Pharmacology 76 11 1485 1489 1:CAS:528:DC%2BD1cXhtl2qtLfI 18694732
37. DD Zhang 2006 Mechanistic studies of the Nrf2-Keap1 signaling pathway Drug Metabolism Reviews 38 4 769 789 1:CAS:528:DC%2BD28XhtlCnur%2FP 17145701
38. W Lin, et al. 2006 Regulation of Nrf2 transactivation domain activity by p160 RAC3/SRC3 and other nuclear co-regulators Journal of Biochemistry and Molecular Biology 39 3 304 310 1:CAS:528:DC%2BD28XmsVOmsb0%3D 16756760
39. IM Copple, et al. 2010 The keap1-nrf2 cellular defense pathway: mechanisms of regulation and role in protection against drug-induced toxicity Handbook of Experimental Pharmacology 196 233 266 1:CAS:528:DC%2BC3cXnvVynu7k%3D 20020265
40. SB Cullinan, et al. 2004 The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase Molecular and Cellular Biology 24 19 8477 8486 1:CAS:528:DC%2BD2cXnvVakt7k%3D 15367669
41. W Li, et al. 2010 An internal ribosomal entry site mediates redox-sensitive translation of Nrf2 Nucleic Acids Research 38 3 778 788 19934254
42. AT Dinkova-Kostova, et al. 2002 Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants Proceedings of the National Academy of Sciences of the United States of America 99 18 11908 11913 1:CAS:528: DC%2BD38XntFWqtb0%3D 12193649
43. AT Dinkova-Kostova WD Holtzclaw N Wakabayashi 2005 Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metalloprotein Biochemistry 44 18 6889 6899 1:CAS:528:DC%2BD2MXjt1Oktbg%3D 15865434
44. W Li AN Kong 2009 Molecular mechanisms of Nrf2-mediated antioxidant response Molecular Carcinogenesis 48 2 91 104 1:CAS:528:DC%2BD1MXitlCls7k%3D 18618599
45. T Nguyen, et al. 2003 Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26S proteasome The Journal of Biological Chemistry 278 7 4536 4541 1:CAS:528:DC%2BD3sXhtVKmurs%3D 12446695
46. HC Huang T Nguyen CB Pickett 2002 Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription The Journal of Biological Chemistry 277 45 42769 42774 1:CAS:528: DC%2BD38Xos1ent7g%3D 12198130
47. K Nakaso, et al. 2003 PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells FEBS Letters 546 2-3 181 184 1:CAS:528:DC%2BD3sXkvVKjsb4%3D 12832036
48. LM Zipper RT Mulcahy 2003 Erk activation is required for Nrf2 nuclear localization during pyrrolidine dithiocarbamate induction of glutamate cysteine ligase modulatory gene expression in HepG2 cells Toxicological Sciences 73 1 124 134 1:CAS:528:DC%2BD3sXjsVKlurw%3D 12657749
49. LM Zipper RT Mulcahy 2000 Inhibition of ERK and p38 MAP kinases inhibits binding of Nrf2 and induction of GCS genes Biochemical and Biophysical Research Communications 278 2 484 492 1:CAS:528:DC%2BD3cXotlKktro%3D 11097862
50. G Shen, et al. 2004 Regulation of Nrf2 transactivation domain activity. The differential effects of mitogen-activated protein kinase cascades and synergistic stimulatory effect of Raf and CREB- binding protein The Journal of Biological Chemistry 279 22 23052 23060 1:CAS:528:DC%2BD2cXkt1Gis7w%3D 15020583
51. KL Cheung TO Khor AN Kong 2009 Synergistic effect of combination of phenethyl isothiocyanate and sulforaphane or curcumin and sulforaphane in the inhibition of inflammation Pharmaceutical Research 26 1 224 231 1:CAS:528:DC%2BD1MXkvVKksg%3D%3D 18841446
52. C Xu, et al. 2006 Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2 Molecular Cancer Therapeutics 5 8 1918 1926 1:CAS:528:DC%2BD28XosVans7w%3D 16928811
53. E Balogun, et al. 2003 Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element The Biochemical Journal 371 Pt 3 887 895 1:CAS:528:DC%2BD3sXjtFKlsrY%3D 12570874
54. HK Na, et al. 2008 (-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells Archives of Biochemistry and Biophysics 476 2 171 177 1:CAS:528:DC%2BD1cXpsVGjsbg%3D 18424257
55. F Hong ML Freeman DC Liebler 2005 Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane Chemical Research in Toxicology 18 12 1917 1926 1:CAS:528:DC%2BD2MXhtFynu7fN 16359182
56. A Mantovani, et al. 2008 Cancer-related inflammation Nature 454 7203 436 444 1:CAS:528:DC%2BD1cXovV2mtbg%3D 18650914
57. A Mantovani 2010 Molecular pathways linking inflammation and cancer Current Molecular Medicine 10 4 369 373 1:CAS:528:DC%2BC3cXmsVamsb4%3D 20455855
58. F Colotta, et al. 2009 Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis 30 7 1073 1081 1:CAS:528:DC%2BD1MXot1CisL8%3D 19468060
59. FR Greten, et al. 2004 IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer Cell 118 3 285 296 1:CAS:528: DC%2BD2cXmslKrs7o%3D 15294155
60. R Sen D Baltimore 1986 Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism Cell 47 6 921 928 1:CAS:528:DyaL2sXot1Oltw%3D%3D 3096580
61. HL Pahl 1999 Activators and target genes of Rel/NF-kappaB transcription factors Oncogene 18 49 6853 6866 1:CAS:528:DyaK1MXotVyhtL0%3D 10602461
62. M Karin Y Ben-Neriah 2000 Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity Annual Review of Immunology 18 621 663 1:CAS:528:DC%2BD3cXjs1Gmtro%3D 10837071
63. J Inoue, et al. 1992 I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family Cell 68 6 1109 1120 1:CAS:528:DyaK3sXitVOktLo%3D 1339305
64. MD Jacobs SC Harrison 1998 Structure of an IkappaBalpha/NF-kappaB complex Cell 95 6 749 758 1:CAS:528:DyaK1MXivVGk 9865693
65. G Bonizzi M Karin 2004 The two NF-kappaB activation pathways and their role in innate and adaptive immunity Trends in Immunology 25 6 280 288 1:CAS:528:DC%2BD2cXktVKqs7s%3D 15145317
66. T Luedde, et al. 2007 Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma Cancer Cell 11 2 119 132 1:CAS:528:DC%2BD2sXitVartLs%3D 17292824
67. A Garg BB Aggarwal 2002 Nuclear transcription factor-kappaB as a target for cancer drug development Leukemia 16 6 1053 1068 1:CAS:528: DC%2BD38XksFOnurs%3D 12040437
68. G Sethi B Sung BB Aggarwal 2008 Nuclear factor-kappaB activation: from bench to bedside Experimental Biology and Medicine (Maywood) 233 1 21 31 1:CAS:528:DC%2BD1cXhsVeqsQ%3D%3D
69. A Sica, et al. 2008 Macrophage polarization in tumour progression Seminars in Cancer Biology 18 5 349 355 1:CAS:528:DC%2BD1cXpsVGmsLo%3D 18467122
70. SK Biswas A Sica CE Lewis 2008 Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms Journal of Immunology 180 4 2011 2017 1:CAS:528:DC%2BD1cXhsVShtrY%3D
71. JW Pollard 2004 Tumour-educated macrophages promote tumour progression and metastasis Nature Reviews. Cancer 4 1 71 78 1:CAS:528:DC%2BD2cXos12qtA%3D%3D 14708027
72. CE Lewis JW Pollard 2006 Distinct role of macrophages in different tumor microenvironments Cancer Research 66 2 605 612 1:CAS:528:DC%2BD28XlsFOmtw%3D%3D 16423985
73. A Mancino T Lawrence 2010 Nuclear factor-kappaB and tumor-associated macrophages Clinical Cancer Research 16 3 784 789 1:CAS:528:DC%2BC3cXhs1aru7c%3D 20103670
74. W Lin, et al. 2008 Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway Biochemical Pharmacology 76 8 967 973 1:CAS:528:DC%2BD1cXht1Sms7nM 18755157
75. KS Chun, et al. 2003 Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation Carcinogenesis 24 9 1515 1524 1:CAS:528:DC%2BD3sXnt1KjsrY%3D 12844482
76. S Reuter, et al. 2008 Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells Biochemical Pharmacology 76 11 1340 1351 1:CAS:528:DC%2BD1cXhtl2qtLbM 18755156
77. DI Sun, et al. 2008 Bisacurone inhibits adhesion of inflammatory monocytes or cancer cells to endothelial cells through down-regulation of VCAM-1 expression International Immunopharmacology 8 9 1272 1281 1:CAS:528: DC%2BD1cXotlGitbk%3D 18602074
78. C Wang S Li MW Wang 2010 Evodiamine-induced human melanoma A375-S2 cell death was mediated by PI3K/Akt/caspase and Fas-L/NF-kappaB signaling pathways and augmented by ubiquitin-proteasome inhibition Toxicology In Vitro 24 3 898 904 1:CAS:528:DC%2BC3cXjtVSgs7k%3D 20005289
79. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70 1:CAS:528:DC%2BD3cXks1CktA%3D%3D 10647931
80. LY Li X Luo X Wang 2001 Endonuclease G is an apoptotic DNase when released from mitochondria Nature 412 6842 95 99 1:CAS:528:DC%2BD3MXlt1Cqsr0%3D 11452314
81. X Wang 2001 The expanding role of mitochondria in apoptosis Genes & Development 15 22 2922 2933 1:CAS:528:DC%2BD3MXovVOrtbs%3D
82. NN Danial SJ Korsmeyer 2004 Cell death: critical control points Cell 116 2 205 219 1:CAS:528:DC%2BD2cXhtValsrY%3D 14744432
83. L Scorrano, et al. 2003 BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis Science 300 5616 135 139 1:CAS:528:DC%2BD3sXis1Cgt7Y%3D 12624178
84. M Suzuki RJ Youle N Tjandra 2000 Structure of Bax: coregulation of dimer formation and intracellular localization Cell 103 4 645 654 1:CAS:528: DC%2BD3cXot1Gnu7c%3D 11106734
85. A Letai 2005 Pharmacological manipulation of Bcl-2 family members to control cell death The Journal of Clinical Investigation 115 10 2648 2655 1:CAS:528:DC%2BD2MXhtVygt7jN 16200198
86. A Ashkenazi VM Dixit 1998 Death receptors: signaling and modulation Science 281 5381 1305 1308 1:CAS:528:DyaK1cXlvVegsL0%3D 9721089
87. MR Sprick H Walczak 2004 The interplay between the Bcl-2 family and death receptor-mediated apoptosis Biochimica et Biophysica Acta 1644 2-3 125 132 1:CAS:528:DC%2BD2cXhslWgu7Y%3D 14996497
88. A Ashkenazi 2008 Targeting the extrinsic apoptosis pathway in cancer Cytokine & Growth Factor Reviews 19 3-4 325 331 1:CAS:528: DC%2BD1cXnt1aks7o%3D
89. BC Barnhart ME Peter 2003 The TNF receptor 1: a split personality complex Cell 114 2 148 150 1:CAS:528:DC%2BD3sXlvFCgu7w%3D 12887914
90. FC Kischkel, et al. 1995 Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor The EMBO Journal 14 22 5579 5588 1:CAS:528:DyaK2MXpslamtr4%3D 8521815
91. FC Kischkel, et al. 2000 Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5 Immunity 12 6 611 620 1:CAS:528:DC%2BD3cXkslagtbw%3D 10894161
92. BC Barnhart EC Alappat ME Peter 2003 The CD95 type I/type II model Seminars in Immunology 15 3 185 193 1:CAS:528:DC%2BD3sXmsl2rtb8%3D 14563117
93. J Ma, et al. 2001 Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells Planta Medica 67 8 754 757 1:CAS:528:DC%2BD3MXosVylt74%3D 11731922
94. W Tang, et al. 2006 Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells Life Sciences 80 3 205 211 1:CAS:528:DC%2BD28Xht12qtLnJ 17007887
95. JY Cheung, et al. 2005 Polyphyllin D is a potent apoptosis inducer in drug-resistant HepG2 cells Cancer Letters 217 2 203 211 15617838
96. MS Lee, et al. 2005 Effects of polyphyllin D, a steroidal saponin in Paris polyphylla, in growth inhibition of human breast cancer cells and in xenograft Cancer Biology & Therapy 4 11 1248 1254 1:CAS:528: DC%2BD28XkvFGhtb8%3D
97. DD Ma, et al. 2009 Polyphyllin D exerts potent anti-tumour effects on Lewis cancer cells under hypoxic conditions The Journal of International Medical Research 37 3 631 640 1:CAS:528:DC%2BD1MXhtFSqtrfP 19589245
98. TA Mace, et al. 2006 The potential of the tumor microenvironment to influence Apo2L/TRAIL induced apoptosis Immunological Investigations 35 3-4 279 296 1:CAS:528:DC%2BD28XpvVCksrg%3D 16916755
99. A Ashkenazi 2002 Targeting death and decoy receptors of the tumour-necrosis factor superfamily Nature Reviews. Cancer 2 6 420 430 1:CAS:528:DC%2BD38Xksl2ltr4%3D 12189384
100. T Naka, et al. 2002 Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice Cancer Research 62 20 5800 5806 1:CAS:528:DC%2BD38XotFyktrY%3D 12384541
101. R Ravi A Bedi 2002 Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L) Cancer Research 62 6 1583 1587 1:CAS:528:DC%2BD38XisVSis7s%3D 11912124
102. N Clarke, et al. 2005 TRAIL: at the center of drugable anti-tumor pathways Cell Cycle 4 7 914 918 1:CAS:528:DC%2BD28XhslCrurg%3D 15970670
103. L Zhang, et al. 2010 Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis Nature 464 7291 1058 1061 1:CAS:528: DC%2BC3cXjvFWjs7Y%3D 20348907
104. CA Wicker, et al. 2010 BITC sensitizes pancreatic adenocarcinomas to TRAIL-induced apoptosis Cancer Growth Metastasis 2009 2 45 55 20559452
105. DH Lee JG Rhee YJ Lee 2009 Reactive oxygen species up-regulate p53 and Puma; a possible mechanism for apoptosis during combined treatment with TRAIL and wogonin British Journal of Pharmacology 157 7 1189 1202 1:CAS:528: DC%2BD1MXhtVelt7bN 19438509
106. IR Hart IJ Fidler 1981 The implications of tumor heterogeneity for studies on the biology of cancer metastasis Biochimica et Biophysica Acta 651 1 37 50 1:CAS:528:DyaL3MXls1Kmtr4%3D 7025905
107. SA Eccles DR Welch 2007 Metastasis: recent discoveries and novel treatment strategies Lancet 369 9574 1742 1757 1:CAS:528:DC%2BD2sXlsFertrc%3D 17512859
108. IJ Fidler 2003 The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited Nature Reviews. Cancer 3 6 453 458 1:CAS:528: DC%2BD3sXktFOnsbg%3D 12778135
109. AE Karnoub, et al. 2007 Mesenchymal stem cells within tumour stroma promote breast cancer metastasis Nature 449 7162 557 563 1:CAS:528: DC%2BD2sXhtFagt7fI 17914389
110. AF Chambers 2009 Influence of diet on metastasis and tumor dormancy Clinical & Experimental Metastasis 26 1 61 66 1:CAS:528:DC%2BD1MXhtVCgt78%3D
111. MD Cameron, et al. 2000 Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency Cancer Research 60 9 2541 2546 1:CAS:528:DC%2BD3cXjtV2qtb4%3D 10811137
112. R Kalluri RA Weinberg 2009 The basics of epithelial-mesenchymal transition The Journal of Clinical Investigation 119 6 1420 1428 1:CAS:528:DC%2BD1MXntVCjtr0%3D 19487818
113. D Tarin EW Thompson DF Newgreen 2005 The fallacy of epithelial mesenchymal transition in neoplasia Cancer Research 65 14 5996 6000 1:CAS:528:DC%2BD2MXmt1ehtrs%3D 16024596 discussion 6000-1
114. JP Thiery 2002 Epithelial-mesenchymal transitions in tumour progression Nature Reviews. Cancer 2 6 442 454 1:CAS:528:DC%2BD38Xksl2ltr8%3D 12189386
115. J Yang RA Weinberg 2008 Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis Developmental Cell 14 6 818 829 1:CAS:528:DC%2BD1cXnsVCrs7g%3D 18539112
116. H Hugo, et al. 2007 Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression Journal of Cellular Physiology 213 2 374 383 1:CAS:528:DC%2BD2sXhtFKnu7rE 17680632
117. MJ Bissell PA Kenny DC Radisky 2005 Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes Cold Spring Harbor Symposia on Quantitative Biology 70 343 356 1:CAS:528:DC%2BD28XoslCgsLg%3D 16869771
118. JC Tse R Kalluri 2007 Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment Journal of Cellular Biochemistry 101 4 816 829 1:CAS:528:DC%2BD2sXnvVSqu70%3D 17243120
119. A Zhao, et al. 2000 The effects of the expression of VEGF and KDR on the angiogenesis, growth and metastasis of hepatocellular carcinoma Zhonghua Wai Ke Za Zhi 38 6 453 456 1:STN:280:DC%2BD387gtlChsA%3D%3D 11832083
120. O Gallo, et al. 2001 Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis Neoplasia 3 1 53 61 1:CAS:528:DC%2BD3MXis1agu7g%3D 11326316
121. T Mukherjee, et al. 2003 Ets-1 and VEGF expression correlates with tumor angiogenesis, lymph node metastasis, and patient survival in esophageal squamous cell carcinoma Journal of Cancer Research and Clinical Oncology 129 7 430 436 1:CAS:528:DC%2BD3sXmtVKksb0%3D 12851814
122. J Zhang, et al. 2007 Suppression of breast cancer metastasis through the inhibition of VEGF-mediated tumor angiogenesis Cancer Therapy 5 273 286 18548129
123. A Hanyu, et al. 2009 Functional in vivo optical imaging of tumor angiogenesis, growth, and metastasis prevented by administration of anti-human VEGF antibody in xenograft model of human fibrosarcoma HT1080 cells Cancer Science 100 11 2085 2092 1:CAS:528:DC%2BD1MXhsVSktLbK 19719773
124. H Zheng, et al. 2006 Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma Anticancer Research 26 5A 3579 3583 1:CAS:528:DC%2BD28Xht1ersLnP 17094486
125. S Kurahara, et al. 1999 Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis Head & Neck 21 7 627 638 (Pubitemid 29459868)
126. M Morini, et al. 2000 The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity International Journal of Cancer 87 3 336 342
127. JS Chen, et al. 2009 Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: association with MMP-9 Hepatology Research 39 2 177 186 1:CAS:528:DC%2BD1MXjvVygsrk%3D 19208038
128. P Zigrino, et al. 2009 Stromal expression of MMP-13 is required for melanoma invasion and metastasis The Journal of Investigative Dermatology 129 11 2686 2693 1:CAS:528:DC%2BD1MXht1GntbzE 19516266
129. CT Tan, et al. 2008 CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13 - dependent invasion via the ERK1/2/AP-1 pathway Carcinogenesis 29 8 1519 1527 1:CAS:528:DC%2BD1cXhtVSis7vE 18487224
130. JG Naglich, et al. 2001 Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291 Cancer Research 61 23 8480 8485 1:CAS:528:DC%2BD3MXptFCktbc%3D 11731431
131. K Shinoda, et al. 2003 A novel matrix metalloproteinase inhibitor, FYK-1388 suppresses tumor growth, metastasis and angiogenesis by human fibrosarcoma cell line International Journal of Oncology 22 2 281 288 1:CAS:528:DC%2BD3sXhtV2ltrg%3D 12527923
132. JS Blackburn, et al. 2007 RNA interference inhibition of matrix metalloproteinase-1 prevents melanoma metastasis by reducing tumor collagenase activity and angiogenesis Cancer Research 67 22 10849 10858 1:CAS:528: DC%2BD2sXhtlSlsL7J 18006830
133. CR Pradeep G Kuttan 2003 Effect of beta-carotene on the inhibition of lung metastasis in mice Phytomedicine 10 2-3 159 164 1:CAS:528: DC%2BD3sXksFGktLw%3D 12725570
134. CS Huang JW Liao ML Hu 2008 Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic nude mice The Journal of Nutrition 138 3 538 543 18287363
135. CK Chow 2008 The relative efficacy of lycopene and beta-carotene in inhibiting experimental metastasis of human hepatoma SK-Hep-1 cells in athymic nude mice The Journal of Nutrition 138 11 2289 1:CAS:528:DC%2BD1cXht1ymtr%2FK 18936233 author reply 2290
136. RP Gude LG Menon SG Rao 2001 Effect of Caffeine, a xanthine derivative, in the inhibition of experimental lung metastasis induced by B16F10 melanoma cells Journal of Experimental & Clinical Cancer Research 20 2 287 292 1:CAS:528:DC%2BD3MXlslGrsLc%3D
137. H Yang, et al. 2004 Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis Clinical & Experimental Metastasis 21 8 719 735 1:CAS:528:DC%2BD2MXnvVWrsbk%3D
138. YC Lim, et al. 2008 (-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells Cancer Letters 271 1 140 152 1:CAS:528:DC%2BD1cXht1Sis7nL 18632202
139. S Shankar, et al. 2008 EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer Frontiers in Bioscience 13 440 452 17981559
140. Y Kimura H Okuda 2001 Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma- bearing mice The Journal of Nutrition 131 6 1844 1849 1:CAS:528:DC%2BD3MXkt12ksbg%3D 11385077
141. YL Weng, et al. 2010 Oral administration of resveratrol in suppression of pulmonary metastasis of BALB/c mice challenged with CT26 colorectal adenocarcinoma cells Molecular Nutrition & Food Research 54 2 259 67 1:CAS:528:DC%2BC3cXhs1amtLo%3D
142. H Wu, et al. 2008 Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1 alpha expression in colon carcinoma cells Biomedicine & Pharmacotherapy 62 9 613 621 1:CAS:528:DC%2BD1cXht12ns7jN
143. JM Connolly XH Liu DP Rose 1997 Effects of dietary menhaden oil, soy, and a cyclooxygenase inhibitor on human breast cancer cell growth and metastasis in nude mice Nutrition and Cancer 29 1 48 54 1:CAS:528:DyaK2sXns1ynur4%3D 9383784
144. L Yan D Li JA Yee 2002 Dietary supplementation with isolated soy protein reduces metastasis of mammary carcinoma cells in mice Clinical & Experimental Metastasis 19 6 535 540 1:CAS:528:DC%2BD38Xnt1agsLw%3D
145. D Li, et al. 2004 Dietary supplementation with high-selenium soy protein reduces pulmonary metastasis of melanoma cells in mice The Journal of Nutrition 134 6 1536 1540 1:CAS:528:DC%2BD2cXkslyksLo%3D 15173425
146. AV Singh, et al. 2006 Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis Cancer Research 66 3 1851 1858 1:CAS:528:DC%2BD28XpsVektw%3D%3D 16452247
147. LG Menon, et al. 1998 Effect of isoflavones genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F-10 melanoma cells Nutrition and Cancer 30 1 74 77 1:CAS:528:DyaK1cXhs1Sjsr4%3D 9507517
148. SA Vantyghem, et al. 2005 Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model Cancer Research 65 8 3396 3403 1:CAS:528:DC%2BD2MXjt1yrsLY%3D 15833874
149. RL Schleicher, et al. 1999 The inhibitory effect of genistein on the growth and metastasis of a transplantable rat accessory sex gland carcinoma Cancer Letters 136 2 195 201 1:CAS:528:DyaK1MXhs1Oisbs%3D 10355749
150. H Iishi, et al. 2000 Genistein attenuates peritoneal metastasis of azoxymethane-induced intestinal adenocarcinomas in Wistar rats International Journal of Cancer 86 3 416 420 1:CAS:528:DC%2BD3cXivVyju78%3D
151. Y Li, et al. 2004 Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein Neoplasia 6 4 354 363 1:CAS:528:DC%2BD2cXmslWlu74%3D 15256057
152. WY Lee, et al. 2007 Alterations of metastasis-related genes identified using an oligonucleotide microarray of genistein-treated HCC1395 breast cancer cells Nutrition and Cancer 58 2 239 246 1:CAS:528:DC%2BD2sXhtVOgtL7N 17640171
153. LH El Touny PP Banerjee 2007 Genistein induces the metastasis suppressor kangai-1 which mediates its anti-invasive effects in TRAMP cancer cells Biochemical and Biophysical Research Communications 361 1 169 175 17658479
154. Y Gu, et al. 2009 Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma World Journal of Gastroenterology 15 39 4952 4957 1:CAS:528:DC%2BD1MXhtlCiu73M 19842228
155. M Lakshman, et al. 2008 Dietary genistein inhibits metastasis of human prostate cancer in mice Cancer Research 68 6 2024 2032 1:CAS:528: DC%2BD1cXjtFOht7w%3D 18339885
156. MR Young, et al. 1995 Treating tumor-bearing mice with vitamin D3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence Cancer Immunology, Immunotherapy 41 1 37 45 1:CAS:528:DyaK2MXoslars7s%3D 7641218
157. RH Getzenberg, et al. 1997 Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system Urology 50 6 999 1006 1:STN:280:DyaK1c%2FovVWntQ%3D%3D 9426741
158. WB Grant 2008 Vitamin D may reduce prostate cancer metastasis by several mechanisms including blocking Stat3 The American Journal of Pathology 173 5 1589 1590 18948436
159. LL Ooi, et al. 2010 Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis Cancer Research 70 5 1835 1844 1:CAS:528:DC%2BC3cXisFWju74%3D 20160035
160. K El Abdaimi, et al. 2000 The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells Cancer Research 60 16 4412 4418 10969786
161. M Li-Weber 2009 New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin Cancer Treatment Reviews 35 1 57 68 1:CAS:528:DC%2BD1MXhtlSmur0%3D 19004559
162. Q Chen W Peng A Xu 2002 Apoptosis of a human non-small cell lung cancer (NSCLC) cell line, PLA-801, induced by acutiaporberine, a novel bisalkaloid derived from Thalictrum acutifolium (Hand.-Mazz.) Boivin Biochemical Pharmacology 63 8 1389 1396 1:CAS:528:DC%2BD38XjsVSks70%3D 11996879 (Pubitemid 34457953)
163. F Zhao, et al. 2008 Anti-tumor activities of andrographolide, a diterpene from Andrographis paniculata, by inducing apoptosis and inhibiting VEGF level Journal of Asian Natural Products Research 10 5-6 467 473 18464090
164. K Sheeja G Kuttan 2007 Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice Integrative Cancer Therapies 6 1 66 73 1:CAS:528:DC%2BD2sXjs1SrtLk%3D 17351028
165. PC Li, et al. 2008 Artesunate derived from traditional Chinese medicine induces DNA damage and repair Cancer Research 68 11 4347 4351 1:CAS:528:DC%2BD1cXmsFKmurY%3D 18519695
166. T Efferth, et al. 2001 The anti-malarial artesunate is also active against cancer International Journal of Oncology 18 4 767 773 1:CAS:528:DC%2BD3MXivVWqtbw%3D 11251172
167. VB Konkimalla, et al. 2008 Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells Nitric Oxide 19 2 184 191 1:CAS:528:DC%2BD1cXoslWnt7Y%3D 18472018
168. S Li, et al. 2009 Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2/0 myeloma cells through affecting NFkappaB p65 International Journal of Hematology 90 4 513 521 1:CAS:528:DC%2BD1MXhsVWhu73K 19728025
169. J Hou, et al. 2008 Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action Clinical Cancer Research 14 17 5519 5530 1:CAS:528:DC%2BD1cXhtVKmsbnE 18765544
170. T Efferth, et al. 2002 Activity of ascaridol from the anthelmintic herb Chenopodium anthelminticum L. against sensitive and multidrug-resistant tumor cells Anticancer Research 22 6C 4221 4224 1:CAS:528:DC%2BD3sXhtFGms7s%3D 12553060
171. DP Bezerra, et al. 2009 Antitumor activity of the essential oil from the leaves of Croton regelianus and its component ascaridole Chemistry & Biodiversity 6 8 1224 1231 1:CAS:528:DC%2BD1MXhtVOrt77E
172. DI Sun, et al. 2008 Bisacurone inhibits adhesion of inflammatory monocytes or cancer cells to endothelial cells through down-regulation of VCAM-1 expression International Immunopharmacology 8 9 1272 1281 1:CAS:528: DC%2BD1cXotlGitbk%3D 18602074
173. Y Jing, et al. 1999 Boswellic acid acetate induces differentiation and apoptosis in leukemia cell lines Leukemia Research 23 1 43 50 1:CAS:528:DyaK1MXht1Cntro%3D 9933134
174. S Batra, et al. 2010 Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells Molecular Cancer Therapeutics 9 6 1596 1608 1:CAS:528:DC%2BC3cXntFGgsbo%3D 20484017
175. CA Wicker, et al. 2010 BITC sensitizes pancreatic adenocarcinomas to TRAIL-induced apoptosis Cancer Growth Metastasis 2009 2 45 55 20559452
176. R Warin, et al. 2010 Inhibition of human breast cancer xenograft growth by cruciferous vegetable constituent benzyl isothiocyanate Molecular Carcinogenesis 49 5 500 507 1:CAS:528:DC%2BC3cXlt1Wqtbo%3D 20422714
177. KS Chun, et al. 2003 Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation Carcinogenesis 24 9 1515 1524 1:CAS:528:DC%2BD3sXnt1KjsrY%3D 12844482
178. S Reuter, et al. 2008 Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells Biochemical Pharmacology 76 11 1340 1351 1:CAS:528:DC%2BD1cXhtl2qtLbM 18755156
179. BB Aggarwal A Kumar AC Bharti 2003 Anticancer potential of curcumin: preclinical and clinical studies Anticancer Research 23 1A 363 398 1:CAS:528:DC%2BD3sXislaqtLo%3D 12680238
180. D Deeb, et al. 2003 Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells Molecular Cancer Therapeutics 2 1 95 103 1:CAS:528: DC%2BD3sXhtlOit7s%3D 12533677
181. A Barve, et al. 2008 Murine prostate cancer inhibition by dietary phytochemicals-curcumin and phenyethylisothiocyanate Pharmaceutical Research 25 9 2181 2189 1:CAS:528:DC%2BD1cXps1ajtrw%3D 18437538
182. M Pandey S Gupta 2009 Green tea and prostate cancer: from bench to clinic Frontiers in Bioscience (Elite Ed) 1 13 25
183. WS Jeong, et al. 2004 Modulation of AP-1 by natural chemopreventive compounds in human colon HT-29 cancer cell line Pharmaceutical Research 21 4 649 660 1:CAS:528:DC%2BD2cXjsVWqs7g%3D 15139522
184. S Jagtap, et al. 2009 Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases Current Medicinal Chemistry 16 12 1451 1462 1:CAS:528:DC%2BD1MXltVeqtrs%3D 19355899
185. S Liao RA Hiipakka 1995 Selective inhibition of steroid 5 alpha-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate Biochemical and Biophysical Research Communications 214 3 833 838 1:CAS:528:DyaK2MXot1yhs7c%3D 7575552
186. ZG Yang AQ Chen B Liu 2009 Antiproliferation and apoptosis induced by evodiamine in human colorectal carcinoma cells (COLO-205) Chemistry & Biodiversity 6 6 924 933 1:CAS:528:DC%2BD1MXos1amtbk%3D
187. C Wang S Li MW Wang 2010 Evodiamine-induced human melanoma A375-S2 cell death was mediated by PI3K/Akt/caspase and Fas-L/NF-kappaB signaling pathways and augmented by ubiquitin-proteasome inhibition Toxicology In Vitro 24 3 898 904 1:CAS:528:DC%2BC3cXjtVSgs7k%3D 20005289
188. Y Takada Y Kobayashi BB Aggarwal 2005 Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion The Journal of Biological Chemistry 280 17 17203 17212 1:CAS:528:DC%2BD2MXjsFOgtb0%3D 15710601
189. CH Liao, et al. 2005 Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo Carcinogenesis 26 5 968 975 1:CAS:528:DC%2BD2MXjsFOms78%3D 15705600
190. Z Liu, et al. 2009 Modulation of DNA methylation by a sesquiterpene lactone parthenolide The Journal of Pharmacology and Experimental Therapeutics 329 2 505 514 1:CAS:528:DC%2BD1MXlt1Omu7s%3D 19201992
191. K Koprowska M Czyz 2010 Molecular mechanisms of parthenolide's action: old drug with a new face Postȩpy Higieny i Medycyny Doświadczalnej (Online) 64 100 114
192. R Shanmugam, et al. 2006 Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model The Prostate 66 14 1498 1511 1:CAS:528:DC%2BD28XhtFWks7zJ 16921510
193. W Tang, et al. 2006 Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells Life Sciences 80 3 205 211 1:CAS:528:DC%2BD28Xht12qtLnJ 17007887
194. SO Kim, et al. 2005 [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappaB in phorbol ester-stimulated mouse skin Oncogene 24 15 2558 2567 1:CAS:528:DC%2BD2MXivFOhur8%3D 15735738
195. K Ishiguro, et al. 2007 Ginger ingredients reduce viability of gastric cancer cells via distinct mechanisms Biochemical and Biophysical Research Communications 362 1 218 223 1:CAS:528:DC%2BD2sXpsFKks7k%3D 17706603
196. KK Park, et al. 1998 Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice Cancer Letters 129 2 139 144 1:CAS:528:DyaK1cXktFGms74%3D 9719454
197. WK Liu SX Xu CT Che 2000 Anti-proliferative effect of ginseng saponins on human prostate cancer cell line Life Sciences 67 11 1297 1306 1:CAS:528:DC%2BD3cXlslCgsbY%3D 10972198
198. TK Yun 2003 Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds Mutation Research 523-524 63 74 12628504
199. H Nakata, et al. 1998 Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells Japanese Journal of Cancer Research 89 7 733 740 1:CAS:528:DyaK1cXltlCjurg%3D 9738980
200. K Shinkai, et al. 1996 Inhibition of in vitro tumor cell invasion by ginsenoside Rg3 Japanese Journal of Cancer Research 87 4 357 362 1:CAS:528:DyaK28XisFOht7o%3D 8641966
201. SY Lin, et al. 2002 Magnolol suppresses proliferation of cultured human colon and liver cancer cells by inhibiting DNA synthesis and activating apoptosis Journal of Cellular Biochemistry 84 3 532 544 11813258
202. H Liu, et al. 2008 Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer European Journal of Pharmacology 591 1-3 43 51 1:CAS:528:DC%2BD1cXps12lur0%3D 18588872
203. SJ Lee, et al. 2007 Aqueous extract of Magnolia officinalis mediates proliferative capacity, p21WAF1 expression and TNF-alpha-induced NF-kappaB activity in human urinary bladder cancer 5637 cells; involvement of p38 MAP kinase Oncology Reports 18 3 729 736 17671727
204. ER Hahm SV Singh 2007 Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity Molecular Cancer Therapeutics 6 10 2686 2695 1:CAS:528:DC%2BD2sXhtFKltbbK 17938262
205. ER Hahm, et al. 2008 Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction Clinical Cancer Research 14 4 1248 1257 1:CAS:528:DC%2BD1cXhvF2nt7w%3D 18281560
206. N Takai, et al. 2008 Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells Gynecologic Oncology 109 1 107 114 1:CAS:528:DC%2BD1cXktVCis7k%3D 18234298
207. Y Komi, et al. 2009 Mechanism of inhibition of tumor angiogenesis by beta-hydroxyisovalerylshikonin Cancer Science 100 2 269 277 1:CAS:528: DC%2BD1MXhvVyls70%3D 19200258
208. P Ma, et al. 2006 Inducement effect of synthetic indiosides from Solanum indicum L.on apoptosis of human hepatocarcinoma cell line Bel-7402 and its mechanism Ai Zheng 25 4 438 442 1:CAS:528:DC%2BD2sXpsV2lt7w%3D 16613676
209. W Lv, et al. 2008 Jaceosidin induces apoptosis in human ovary cancer cells through mitochondrial pathway Journal of Biomedicine & Biotechnology 2008 394802
210. J Ma, et al. 2001 Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells Planta Medica 67 8 754 757 1:CAS:528:DC%2BD3MXosVylt74%3D 11731922
211. Y Fu, et al. 2004 Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells Biochemical and Biophysical Research Communications 322 1 263 270 1:CAS:528:DC%2BD2cXmslOhtb4%3D 15313200
212. YT Yo, et al. 2009 Licorice and licochalcone-A induce autophagy in LNCaP prostate cancer cells by suppression of Bcl-2 expression and the mTOR pathway Journal of Agricultural and Food Chemistry 57 18 8266 8273 1:CAS:528: DC%2BD1MXhtVGjtb3J 19711916
213. CK Lee, et al. 2008 Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice Basic & Clinical Pharmacology & Toxicology 103 1 48 54 1:CAS:528:DC%2BD1cXotlKisLY%3D
214. XS Liu J Jiang 2006 Molecular mechanism of matrine-induced apoptosis in leukemia K562 cells The American Journal of Chinese Medicine 34 6 1095 1103 1:CAS:528:DC%2BD28Xht12ktbnN 17163597
215. L Ma, et al. 2008 Anticancer effects of the Chinese medicine matrine on murine hepatocellular carcinoma cells Planta Medica 74 3 245 251 1:CAS:528:DC%2BD1cXltFSks7Y%3D 18283616
216. DD Ma, et al. 2009 Polyphyllin D exerts potent anti-tumour effects on Lewis cancer cells under hypoxic conditions The Journal of International Medical Research 37 3 631 640 1:CAS:528:DC%2BD1MXhtFSqtrfP 19589245
217. Q Huang HM Shen CN Ong 2004 Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB Biochemical Pharmacology 68 2 361 371 1:CAS:528:DC%2BD2cXkvV2hsLw%3D 15194008
218. JJ Liu, et al. 2004 Anti-proliferative effects of oridonin on SPC-A-1 cells and its mechanism of action The Journal of International Medical Research 32 6 617 625 1:CAS:528:DC%2BD2cXhtFSgtbrK 15587755
219. CH Leung, et al. 2005 Novel mechanism of inhibition of nuclear factor-kappa B DNA-binding activity by diterpenoids isolated from Isodon rubescens Molecular Pharmacology 68 2 286 297 1:CAS:528:DC%2BD2MXntVSnsr4%3D 15872117
220. TC Hsieh, et al. 2005 Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens Biochemical and Biophysical Research Communications 337 1 224 231 1:CAS:528:DC%2BD2MXhtVKis7%2FI 16176802
221. JJ Liu, et al. 2005 Antiproliferation effects of ponicidin on human myeloid leukemia cells in vitro Oncology Reports 13 4 653 657 1:CAS:528:DC%2BD2MXjtFansL8%3D 15756438
222. K Hayashi, et al. 2002 Contribution of a combination of ponicidin and acyclovir/ganciclovir to the antitumor efficacy of the herpes simplex virus thymidine kinase gene therapy system Human Gene Therapy 13 3 415 423 1:CAS:528:DC%2BD38XhvVaqs78%3D 11860708
223. S Yang, et al. 2003 Triptolide inhibits the growth and metastasis of solid tumors Molecular Cancer Therapeutics 2 1 65 72 1:CAS:528: DC%2BD3sXhtlOit7w%3D 12533674
224. F Zhao, et al. 267 Triptolide alters histone H3K9 and H3K27 methylation state and induces G0/G1 arrest and caspase-dependent apoptosis in multiple myeloma in vitro Toxicology 267 1-3 70 79
225. M Yang, et al. 2008 Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells International Journal of Molecular Medicine 22 4 489 496 1:CAS:528:DC%2BD1cXht1KrurbF 18813856
226. J Lin, et al. 2007 Inhibitory effect of triptolide on glioblastoma multiforme in vitro The Journal of International Medical Research 35 4 490 496 1:CAS:528:DC%2BD2sXhtVers7fJ 17697526 (Pubitemid 47261111)
227. R Yu, et al. 1998 Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity Cancer Research 58 3 402 408 1:CAS:528:DyaK1cXnsFejtg%3D%3D 9458080
228. SJ Wu LT Ng CC Lin 2005 Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells European Journal of Pharmacology 518 2-3 96 106 1:CAS:528:DC%2BD2MXosVCktrw%3D 16054126
229. D Trachootham, et al. 2006 Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate Cancer Cell 10 3 241 252 1:CAS:528:DC%2BD28XhtVSlu73L 16959615
230. KL Cheung AN Kong 2010 Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention The AAPS Journal 12 1 87 97 1:CAS:528:DC%2BC3cXisVGrt74%3D 20013083
231. KL Cheung TO Khor AN Kong 2009 Synergistic effect of combination of phenethyl isothiocyanate and sulforaphane or curcumin and sulforaphane in the inhibition of inflammation Pharmaceutical Research 26 1 224 231 1:CAS:528:DC%2BD1MXkvVKksg%3D%3D 18841446
232. SS Hecht 1995 Chemoprevention by isothiocyanates Journal of Cellular Biochemistry. Supplement 22 195 209 1:STN:280:DyaK28%2FhtVegsA%3D%3D 8538199
233. KL Cheung, et al. 2010 Differential in vivo mechanism of chemoprevention of tumor formation in azoxymethane/dextran sodium sulfate mice by PEITC and DBM Carcinogenesis 31 5 880 885 1:CAS:528:DC%2BC3cXlvVWjsbk%3D 19959557
234. TO Khor, et al. 2006 Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice Cancer Research 66 2 613 621 1:CAS:528: DC%2BD28XlsFOmtA%3D%3D 16423986
235. SS Hecht 1999 Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism The Journal of Nutrition 129 3 768S 774S 1:CAS:528:DyaK1MXhvFalsL8%3D 10082787
236. AA Powolny SV Singh 2008 Plumbagin-induced apoptosis in human prostate cancer cells is associated with modulation of cellular redox status and generation of reactive oxygen species Pharmaceutical Research 25 9 2171 2180 1:CAS:528:DC%2BD1cXps1ajtrg%3D 18213451
237. YL Hsu, et al. 2006 Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo The Journal of Pharmacology and Experimental Therapeutics 318 2 484 494 1:CAS:528:DC%2BD28XnslOls7w%3D 16632641
238. RK Hansen, et al. 1997 Quercetin inhibits heat shock protein induction but not heat shock factor DNA-binding in human breast carcinoma cells Biochemical and Biophysical Research Communications 239 3 851 856 1:CAS:528:DyaK2sXnsVKqt7g%3D 9367858
239. S HemaIswarya M Doble 2006 Potential synergism of natural products in the treatment of cancer Phytotherapy Research 20 4 239 249 1:CAS:528: DC%2BD28Xkslams7g%3D 16557604
240. YH Jung, et al. 2010 Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5 Life Sciences 86 9-10 351 357 1:CAS:528:DC%2BC3cXit1Ontr4%3D 20096292
241. YH Kim, et al. 2008 Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway Biochemical Pharmacology 75 10 1946 1958 1:CAS:528:DC%2BD1cXlsFOms7o%3D 18377872
242. S Miyamoto, et al. 2010 Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice Chemistry & Biology Interact 183 2 276 283 1:CAS:528:DC%2BD1MXhs1WnsL3O
243. S Lin, et al. 2003 Rhein inhibits TPA-induced activator protein-1 activation and cell transformation by blocking the JNK-dependent pathway International Journal of Oncology 22 4 829 833 1:CAS:528:DC%2BD3sXislWhsb8%3D 12632075
244. WW Lai, et al. 2009 Rhein induced apoptosis through the endoplasmic reticulum stress, caspase- and mitochondria-dependent pathways in SCC-4 human tongue squamous cancer cells In Vivo 23 2 309 316 1:CAS:528:DC%2BD1MXltFyisrk%3D 19414420
245. YJ Lin YS Zhen 2009 Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice Anti-Cancer Drugs 20 1 65 72 1:CAS:528:DC%2BD1MXhvVaisg%3D%3D 19343002
246. SH Hsu, et al. 1996 Solamargine purified from Solanum incanum Chinese herb triggers gene expression of human TNFR I which may lead to cell apoptosis Biochemical and Biophysical Research Communications 229 1 1 5 1:CAS:528:DyaK28Xnt12ktLo%3D 8954074
247. LF Liu, et al. 2004 Action of solamargine on human lung cancer cells-enhancement of the susceptibility of cancer cells to TNFs FEBS Letters 577 1-2 67 74 1:CAS:528:DC%2BD2cXpsFektb0%3D 15527763
248. CH Liang, et al. 2007 Solamargine upregulation of Fas, downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cells Molecular Nutrition & Food Research 51 8 999 1005 1:CAS:528:DC%2BD2sXhtVSgtLfL
249. CH Liang, et al. 2004 Action of solamargine on TNFs and cisplatin-resistant human lung cancer cells Biochemical and Biophysical Research Communications 322 3 751 758 1:CAS:528:DC%2BD2cXntFeqs7c%3D 15336528
250. P Sestili, et al. 2010 Sulforaphane induces DNA single strand breaks in cultured human cells Mutation Research 689 1-2 65 73 1:CAS:528: DC%2BC3cXotVSrtL4%3D 20510253
251. DO Moon, et al. 2010 Sulforaphane decreases viability and telomerase activity in hepatocellular carcinoma Hep3B cells through the reactive oxygen species-dependent pathway Cancer Letter 295 2 260 266 1:CAS:528: DC%2BC3cXotVWksro%3D
252. E Ho JD Clarke RH Dashwood 2009 Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention The Journal of Nutrition 139 12 2393 2396 1:CAS:528:DC%2BC3cXhsFeisLk%3D 19812222
253. SH Kim SV Singh 2009 D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells Molecular Cancer Therapeutics 8 7 1946 1954 1:CAS:528:DC%2BD1MXosVymsbo%3D 19584240
254. Y Shan, et al. 2009 Sulforaphane down-regulates COX-2 expression by activating p38 and inhibiting NF-kappaB-DNA-binding activity in human bladder T24 cells International Journal of Oncology 34 4 1129 1134 1:CAS:528: DC%2BD1MXkt1eisrc%3D 19287971
255. S Shankar S Ganapathy RK Srivastava 2008 Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis Clinical Cancer Research 14 21 6855 6866 1:CAS:528:DC%2BD1cXhtlens7nN 18980980
256. YS Keum, et al. 2009 Pharmacokinetics and pharmacodynamics of broccoli sprouts on the suppression of prostate cancer in transgenic adenocarcinoma of mouse prostate (TRAMP) mice: implication of induction of Nrf2, HO-1 and apoptosis and the suppression of Akt-dependent kinase pathway Pharmaceutical Research 26 10 2324 2331 1:CAS:528:DC%2BD1MXpsF2itL4%3D 19669099
257. MC Myzak, et al. 2007 Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects Experimental Biology and Medicine (Maywood) 232 2 227 234 1:CAS:528:DC%2BD2sXhsVWjt7g%3D
258. WY Lee LC Chiu JH Yeung 2008 Cytotoxicity of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on HepG2 cells in relation to glutathione perturbation Food and Chemical Toxicology 46 1 328 338 1:CAS:528: DC%2BD2sXhsVCgu7rP 17892911
259. IT Nizamutdinova, et al. 2008 Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells International Journal of Oncology 33 3 485 491 1:CAS:528:DC%2BD1cXht1Wmu7rO 18695877
260. MA El-Mahdy, et al. 2005 Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells International Journal of Cancer 117 3 409 417 1:CAS:528:DC%2BD2MXhtFant7rF
261. H Gali-Muhtasib, et al. 2004 Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism International Journal of Oncology 25 4 857 866 1:CAS:528:DC%2BD2cXovFWlurY%3D 15375533
262. OA Badary 1999 Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice Journal of Ethnopharmacology 67 2 135 142 1:CAS:528:DyaK1MXlvVWrsrc%3D 10619376
263. BB Aggarwal, et al. 2008 Potential of spice-derived phytochemicals for cancer prevention Planta Medica 74 13 1560 1569 1:CAS:528:DC%2BD1cXhtl2hsb3P 18612945
264. M Roepke, et al. 2007 Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells Cancer Biology & Therapy 6 2 160 169 1:CAS:528:DC%2BD2sXhtVeqsbzO
265. AM Shoieb, et al. 2003 In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone International Journal of Oncology 22 1 107 113 1:CAS:528:DC%2BD3sXhsVSnsQ%3D%3D 12469192
266. H Gali-Muhtasib A Roessner R Schneider-Stock 2006 Thymoquinone: a promising anti-cancer drug from natural sources The International Journal of Biochemistry & Cell Biology 38 8 1249 1253 1:CAS:528:DC%2BD28XksVGgsro%3D
267. T Yi, et al. 2008 Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways Molecular Cancer Therapeutics 7 7 1789 1796 1:CAS:528:DC%2BD1cXoslCgtL0%3D 18644991
268. K Zhang, et al. 2008 Wogonin induces the granulocytic differentiation of human NB4 promyelocytic leukemia cells and up-regulates phospholipid scramblase 1 gene expression Cancer Science 99 4 689 695 1:CAS:528:DC%2BD1cXlsFKjs7s%3D 18377421
269. L Yang, et al. 2009 Wogonin induces G1 phase arrest through inhibiting Cdk4 and cyclin D1 concomitant with an elevation in p21Cip1 in human cervical carcinoma HeLa cells Biochemistry and Cell Biology 87 6 933 942 1:CAS:528:DC%2BD1MXhsVCqu73J 19935879
270. E Lee, et al. 2009 Inhibition of P-glycoprotein by wogonin is involved with the potentiation of etoposide-induced apoptosis in cancer cells Annals of the New York Academy of Sciences 1171 132 136 1:CAS:528:DC%2BD1MXht1SntbrI 19723047
271. H Chung, et al. 2008 Anticancer effects of wogonin in both estrogen receptor-positive and -negative human breast cancer cell lines in vitro and in nude mice xenografts International Journal of Cancer 122 4 816 822 1:CAS:528:DC%2BD1cXhsFShs7o%3D
272. JY Cheung, et al. 2005 Polyphyllin D is a potent apoptosis inducer in drug-resistant HepG2 cells Cancer Letters 217 2 203 211 15617838
273. MS Lee, et al. 2005 Effects of polyphyllin D, a steroidal saponin in Paris polyphylla, in growth inhibition of human breast cancer cells and in xenograft Cancer Biology & Therapy 4 11 1248 1254 1:CAS:528: DC%2BD28XkvFGhtb8%3D